14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for CYCN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.25 7.01 %
R2 3.19 5.00 %
R1 3.15 3.76 %
Current price: 3.04
Support S1 3.03 -0.256 %
S2 2.99 -1.50 %
S3 2.93 -3.51 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.37 10.86 %
R2 3.20 5.26 %
R1 3.15 3.62 %
Current price 3.04
Support S1 3.01 -0.99%
S2 2.90 -4.61%
S3 2.82 -7.24%

CYCN Predictions History

1 year ago
JS predicted that CYCN for 2022-05-24 is going $0.605 (14.13%)

1 year ago
sbinder16.243045 predicted that CYCN for 2022-05-24 is going

Rank:

2 years ago
RamboRex3000 predicted that CYCN for 2021-09-07 is going $3.11 (-1.89%)

2 years ago
JS predicted that CYCN for 2021-09-07 is going $3.15 (-0.63%)

2 years ago
JS predicted that CYCN for 2021-05-14 is going $2.81 (-4.42%)

2 years ago
rafael_fc1986.238431 predicted that CYCN for 2021-05-14 is going

Rank:

2 years ago
JS predicted that CYCN for 2021-05-10 is going $2.81 (2.55%)

2 years ago
kazhiryu187 predicted that CYCN for 2021-05-10 is going $2.90 (5.07%)

Rank:

3 years ago
Alan predicted that CYCN for 2020-06-22 is going $5.15 (-2.83%)

3 years ago
JS predicted that CYCN for 2020-05-11 is going $4.21 (-5.18%)

Click to get the best stock tips daily for free!

About Cyclerion TherapeuticsInc.

Cyclerion TherapeuticsInc. Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's dis... CYCN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT